IGIP19162, Hezel, D-US-60010-001, Pancreas, Irinotecan Liposomal Injection
Basic Study Information
Purpose:Location: University of Rochester
The purpose of this study is to look at the efficacy and safety of Irinotecan liposome
injection in combination with other approved drugs used for cancer therapy, namely
5 fluorouracil/leucovorin (5FU/LV) plus oxaliplatin compared to nab-paclitaxel + gemcitabine
treatment in improving the overall survival of patients not previously treated for
metastatic pancreatic cancer.
Lead Researcher (Principal Investigator)
Study Contact InformationStudy Coordinator: Tina Bowdish
Phone: +1 585-275-9475
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search